He notes trials showed semaglutide and tirzepatide kept working for years, yet some people in the real world say their appetite suppression fades.
Recap by typeshit. Post by @drmikehart on Instagram.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
The AI drug discovery founder makes the claim while thanking Andrew Adams for the ARDD2026 aging research conference.
The claims analysis of over 200,000 adults with type 2 diabetes found a 6% lower MACE risk, though doctors note it shows association, not cause, and adherence may play a role.
Loading…